Postmortem studies on a patient with mucopolysaccharidosis type I: Histopathological findings after one year of enzyme replacement therapy

By Yano S.   Moseley K.   Pavlova Z.  

Journal of Inherited Metabolic Disease, Vol. 32, Iss. 1, 2009-12 ,pp. : 53-57

Springer Publishing Company

Access to resources Recommend Favorite

Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I

By Tokic Visnja   Barisic Ingeborg   Huzjak Nevenka   Petkovic Giorgie   Fumic Ksenija   Paschke Eduard  

European Journal of Pediatrics, Vol. 166, Iss. 7, 2007-07 ,pp. : 727-732

Springer Publishing Company

Access to resources Recommend Favorite

IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: A case report

By Martinez-Redondo C.   Ortuño F.   Lozano M.   Jerez A.   del Mar Osma M.   Giraldo P.   Vicente V.  

Journal of Inherited Metabolic Disease, Vol. 32, Iss. 1, 2009-12 ,pp. : 265-267

Springer Publishing Company

Access to resources Recommend Favorite

Enzyme replacement therapy in Fabry disease

By Brady R.   Murray G.   Moore D.   Schiffmann R.  

Journal of Inherited Metabolic Disease, Vol. 24, Iss. 2, 2001-04 ,pp. : 18-24

Springer Publishing Company

Access to resources Recommend Favorite

TYPE I GAUCHER DISEASE IN CHILDREN WITH AND WITHOUT ENZYME THERAPY

By Dweck Altoon   Abrahamov Ayala   Hadas-Halpern Irith   Bdolach-Avram Tali   Zimran Ari   Elstein Deborah  

Pediatric Hematology and Oncology, Vol. 19, Iss. 6, 2002-09 ,pp. : 389-397

Informa Healthcare

Access to resources Recommend Favorite